Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

The Lancet Neurology

Authors: Hans‐Christoph Diener, Ralph L. Sacco, Salim Yusuf, Otto W. Witte, Stephanie Ôunpuu, William A Lawton, Yuko Palesch, Renée H. Martin, Gregory W. Albers, Philip M. Bath, Natan M. Bornstein, Bernard PL Chan, Christopher Chen, Luı́s Cunha, Björn Dahlöf, Jacques De Keyser, Geoffrey A. Donnan, Conrado J. Estol, Philip B. Gorelick, Vivian Gu, Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lü, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam P. VanderMaelen, Thor Voigt, Michael A. Weber, Byung‐Woo Yoon

DOI: https://doi.org/10.1016/s1474-4422(08)70198-4

Publish Year: 2008